new-kit-box new-kit-box new-kit-box

Ki-67 検出のためのウォッシュ不要アッセイ

Catalog Number:

Size

Catalog Number: GC1000

Please Enquire

Catalog Number: GC1002

Please Enquire

Catalog Number: GC1001

Please Enquire


Overview
Protocols
Specifications
Resources
Compare Products

「添加・混合・測定」アッセイにより、2時間以内に細胞増殖を評価

細胞増殖は細胞ベースの研究の基本的なパラメーターです。研究者は現在、代謝の変動に影響を受ける方法を用いて細胞増殖をモニターしており、煩雑な洗浄ステップが必要であったり、増殖の間接的なマーカーであったり、放射性物質、特殊な装置を使用するなどしています。

Lumit® hKi-67イムノアッセイは、細胞増殖の指標としてよく知られているKi-67を追跡するための簡単な添加・混合・測定のプレートベースのアッセイで、洗浄ステップや特殊な検出装置は不要です。発光プレート-リーダー(ルミノメーター)があれば測定可能です。

このアッセイを使用することで、研究者はより高い信頼性を持つデータを生成し、準備作業と結果までの時間を短縮することができます。

Watch the video to hear how researcher Clara Gouez is using the Lumit® Cell Proliferation Assay (Human Ki-67) to advance her gastric cancer research.

Lumit® hKi-67 Immunoassay の仕組み

Ki-67に対する一次抗体は、その特異的かつ感度の高い検出のために選択され、NanoBiT®ルシフェラーゼのLgBiTおよびSmBiTサブユニットで標識されています。Ki-67の存在下で、サブユニットは結合して活性ルシフェラーゼ酵素を形成します。最適化された基質を追加すると、Ki-67レベルに比例した明るい発光シグナルが生成されます。
Illustration showing how the Lumit® hKi-67 Immunoassay works.

シンプルなワンプレートプロトコル、洗浄ステップなし!

Illustration of the Lumit® hKi-67 Immunoassay protocol.
Compared with conventional fixation-based Ki-67 flow cytometry, the assay is significantly simpler and faster, requiring no dissociation or wash steps while still producing robust and reproducible results.

Zeynep Kaya, PhD, Postdoctoral Research Fellow, Prof Andrew Beggs Group, University of Birmingham

Lumit® hKi-67検出の広いダイナミックレンジと特異性

Lumit® hKi-67 Immunoassayの広い線形検出範囲は、ほとんどの細胞モデルで予想されるKi-67レベルをカバーし、Ki-67検出に特異的です。
Line graph showing highly linear luminescence response (r²=0.998) across Jurkat cell titration in a 96-well plate format using the Lumit® Cell Proliferation Assay (Human Ki-67).
Bar graph showing strong luminescence signal in wild-type HeLa cells and near-zero signal in Ki-67 knockout and no-cell controls, demonstrating specific hKi-67 detection using the Lumit® Cell Proliferation Assay (Human Ki-67).
Line graph showing highly linear luminescence response (r²=0.992) across Jurkat cell titration in a 384-well plate format using the Lumit® Cell Proliferation Assay (Human Ki-67).

細胞増殖の減少を測定

Dose-response curves for palbociclib and BAY-1895344 in Jurkat cells, showing neither compound induces cytotoxicity at tested concentrations using the Lumit® Cell Proliferation Assay (Human Ki-67).
Dose-response curves showing palbociclib (EC₅₀=42nM) and BAY-1895344 (EC₅₀=85nM) reduce Ki-67 expression in a dose-dependent manner using the Lumit® Cell Proliferation Assay (Human Ki-67).
Dose-response curves showing palbociclib (EC₅₀>10µM) and BAY-1895344 (EC₅₀=155nM) effects on Jurkat cell metabolic activity using the Lumit® Cell Proliferation Assay (Human Ki-67).
HCT 116細胞(10,000細胞/ウェル、96ウェルプレート)を抗増殖剤nutlin-3Aの濃度を増加させて処理したところ、細胞毒性は誘発されず、Ki-67発現レベルが濃度依存的に減少しました。Ki-67レベルはLumit® hKi-67 Immunoassayで評価され、生存細胞数の変化は並行するアッセイプレートでCyQUANT™ Directを使用して測定されました。

細胞増殖の増加を測定

Bar graph showing treatment of CD8+ T cells with IL-2; a CD3/CD28 T Cell activator reveals only modest T cell proliferation, as measured using the Lumit® Cell Proliferation Assay (Human Ki-67).
Bar graph showing treatment of CD8+ T cells with IL-2; a CD3/CD28 T Cell activator reveals significant upregulation of Ki-67, as measured using the Lumit® Cell Proliferation Assay (Human Ki-67).
ヒトCD8+ T細胞(StemCell Tech)は、80,000細胞/ウェルでプレートされ、CD3/CD28 T細胞活性化剤を10ng/mlのIL-2あり(オレンジ)およびなし(青)で48時間処理されました。Lumit® hKi-67ImmunoassayでKi-67のアップレギュレーションがT細胞増殖(活性化後72時間以上経過してから開始)前に観察され、このアッセイが増殖の早期指標として使用できることを示しています。

Compatible with 3D Culture Methods

Dose-response curves for nutlin-3a in HCT116 3D spheroids comparing the Lumit® Cell Proliferation Assay (hKi-67) protein (EC₅₀=1.8µM) and total ATP content (EC₅₀=3.3µM), showing Ki-67 as a more sensitive early indicator of antiproliferative activity.

In 3D spheroids, decreases in hKi-67 protein levels provide a clear and early indication of antiproliferative activity with a larger response window than a metabolic measure of viable cell number. HCT116 cells (1,000 cells/well) were plated in SBio PrimeSurface 96U plates (ULA; round bottom) and grown for 3 days to form 3D spheroids. The resultant HCT116 spheroids were then treated for 24 hours with increasing concentrations of nutlin-3a. Subsequently, proliferation was assessed with the Lumit® Cell Proliferation Assay (Human Ki-67) and a metabolic activity assay in separate plates. Note: Day 4 untreated HCT116 spheroids were ~440µm in diameter.

Specifications

Catalog Number:

選択製品の構成品内容

Item Part # Size

CellTox™ Green Dye, 1,000X

G873A 1 × 20μl

Human Ki-67 Protein (Partial) Positive Control

GC100A 1 × 25μl

Anti-hKi-67 mAb SmBiT, 400X

GC101A 1 × 60μl

Anti-hKi-67 mAb LgBiT, 400X

GC102A 1 × 60μl

Lumit® Immunoassay Buffer C, 10X

VB115C 1 × 1.8ml

Lumit® Lysis Buffer II, 10X

VB310C 1 × 1.3ml

Ki-67 Assay Substrate

VB321A 1 × 600μl

Lumit® Detection Buffer B

VB406D 1 × 6ml

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

BB

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

CellTox™ Green Dye, 1,000X

G873B 1 × 200μl

Human Ki-67 Protein (Partial) Positive Control

GC100A 1 × 25μl

Anti-hKi-67 mAb SmBiT, 400X

GC101A 5 × 60μl

Anti-hKi-67 mAb LgBiT, 400X

GC102A 5 × 60μl

Lumit® Immunoassay Buffer C, 10X

VB115C 5 × 1.8ml

Lumit® Lysis Buffer II, 10X

VB310C 5 × 1.3ml

Ki-67 Assay Substrate

VB321A 5 × 600μl

Lumit® Detection Buffer B

VB406D 5 × 6ml

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

BB

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

CellTox™ Green Dye, 1,000X

G873B 1 × 200μl

Human Ki-67 Protein (Partial) Positive Control

GC100A 1 × 25μl

Anti-hKi-67 mAb SmBiT, 400X

GC101B 1 × 600μl

Anti-hKi-67 mAb LgBiT, 400X

GC102B 1 × 600μl

Lumit® Immunoassay Buffer C, 10X

VB115D 1 × 18ml

Lumit® Lysis Buffer II, 10X

VB310D 1 × 13ml

Ki-67 Assay Substrate

VB321B 1 × 6ml

Lumit® Detection Buffer B

VB406E 1 × 60ml

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

BB

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

Compare Products

CellTiter-Glo® 2.0

Cell Viability (ATP)

CellTiter-Glo® (original)

Cell Viability (ATP)

CellTiter-Glo® 3D

3D Cell Viability (ATP)

RealTime-Glo™ MT

Real-Time Viability

CellTiter-Fluor™

Non-Lytic Viability

Lumit® hKi-67

Cell Proliferation

Best Use Routine viability & HTS screening Established protocols using original formulation 3D spheroids, organoids, microtissues Kinetic monitoring over time; downstream multiplexing Multiplex first step; cells needed for follow-up assays True proliferation readout independent of metabolism
Key Decision Points
Measures Viability Viability Viability (3D) Viability (kinetic) Viability Proliferation
Cells alive after assay? ✗ Lytic ✗ Lytic ✗ Lytic ✓ Non-lytic ✓ Non-lytic ✗ Lytic
Multiplexing compatible? LimitedLytic—must be terminal step LimitedLytic—must be terminal step LimitedLytic—must be terminal step ✓ ExcellentNon-lytic; pair with any downstream assay ✓ ExcellentNon-lytic; pair with Caspase-Glo®, CTG, etc. ModerateCan multiplex with CellTox™ Green or other fluorescent readouts
Real-time monitoring? ✗ Endpoint ✗ Endpoint ✗ Endpoint ✓ Up to 72hRead same wells repeatedly ✗ Endpoint ✗ Endpoint
3D culture compatible? PartialWorks for small spheroids; use 3D version for dense structures PartialSame as 2.0 ✓ OptimizedEnhanced lysis for dense 3D structures PartialSubstrate must penetrate; best for small/loose 3D models PartialSubstrate access may be limited in dense 3D ✓ YesDetects Ki-67 in cell lysates from any culture format
Assay Attributes
Assay Principle ATP quantitation (luciferase/luciferin) ATP quantitation (luciferase/luciferin) ATP quantitation (enhanced lysis for 3D) Metabolic reduction of pro-substrate to luciferase substrate Live-cell protease activity (GF-AFC cleavage) Ki-67 immunodetection via NanoBiT® complementation
Detection Mode Luminescence Luminescence Luminescence Luminescence Fluorescence400Ex / 505Em Luminescence
Reagent Format Ready-to-use liquid Buffer + lyophilized substrateRequires reconstitution Ready-to-use liquid 2 components(enzyme + substrate) Single reagent Antibody mix + detection reagent
Time to Result 10min 10min ~30min ContinuousFirst read: 1–2h after addition 30min ~2h
Practical Considerations
Plate Formats 96, 384, 1536 96, 384, 1536 96, 384 96, 384 96, 384 96, 384
HTS Suitability ✓ Excellent1536-well capable; fast protocol ✓ Excellent1536-well capable ✓ Good ModerateRequires kinetic reader scheduling ✓ Good ✓ Good
Sensitivity (96-well) ~15 cells/well ~10 cells/well Spheroid-dependent <100 cells/well ~40 cells/well Cell line-dependent